Skip to main content
Equibles
HCA logo

HCA · HCA Healthcare, Inc.

Track HCA — free

Use HCA with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$406.44 +4.38 (+1.09%)
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$91.98B
Shares
221.84M

HCA metrics

80 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$402.06
Market cap
$91.98B

Price action

19 metrics
Price change (1W)
-3.5%
Price change (30D)
+1.7%
Price change (3M)
+12.6%
Price change (6M)
-23.7%
Price change (YTD)
-11.4%
Price change (1Y)
+2.4%
Trailing year
Price change (5Y)
+63.7%
52-week high
$545.13
52-week low
$361.32
Change from 52-week high
-24.1%
Change from 52-week low
+14.5%
Annualized volatility
30.6%
Beta
0.2
RSI (14D)
51.9
Price vs SMA 50
+2.9%
Price vs SMA 200
-8.7%
Avg volume (3M)
1.56M
Relative volume
0.8
Average dollar volume
$611.36M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
221.84M

Valuation

12 metrics
P / E (TTM)
14.2
Trailing earnings · reciprocal yield 7.0%
PEG ratio
1.3
EV / revenue
1.8×
reciprocal yield 54.9%
EV / EBITDA
—
EV / EBIT
—
P / sales
1.2×
reciprocal yield 83.1%
P / book
—
FCF yield
8.6%
TTM · current market cap
Buyback yield
9.9%
P / FCF
11.6
reciprocal yield 8.6%
P / operating cash flow
7.1
reciprocal yield 14.1%
Earnings yield
7.4%

Historical valuation

8 metrics
P / E historical average (3Y)
15.4×
reciprocal yield 6.5%
P / E historical average (5Y)
14.4×
reciprocal yield 7.0%
EV / revenue historical average (3Y)
1.8×
reciprocal yield 54.8%
EV / revenue historical average (5Y)
1.6×
reciprocal yield 61.8%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
0.7%
Trailing 12 months
Payout ratio
10.0%
Shareholder yield
10.7%
Dividend / share (TTM)
$3.00
Dividend growth YoY
+8.7%
Dividend growth streak
5
Last ex-dividend
2026-06-16

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-14

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
8.9%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
$6.79B
Trailing 12 months
Diluted EPS (TTM)
$29.03
FCF margin
10.4%
Effective tax rate
20.2%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$27.90

Growth

11 metrics
Revenue growth YoY
+4.3%
Year over year
Net income growth YoY
+0.6%
Revenue (TTM)
$76.39B
Trailing 12 months
EPS growth YoY
+10.9%
Shares change YoY
-9.1%
Year over year · fewer shares
Revenue CAGR (3Y)
+7.9%
Revenue CAGR (5Y)
+8.0%
EPS CAGR (3Y)
+13.9%
EPS CAGR (5Y)
+21.0%
FCF CAGR (3Y)
+23.1%
FCF CAGR (5Y)
+3.8%

Quality

14 metrics
Return on equity
—
Return on assets
11.1%
Debt / equity
—
Current ratio
0.8
EBITDA (TTM)
—
Free cash flow (TTM)
$7.93B
Quick ratio
0.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$47.08B
Latest balance sheet
Cash & equivalents
$940.00M
Total assets
$61.45B
Total debt
$48.02B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$13.00B
Capital expenditures (TTM)
$5.07B
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$389.00M
R&D / revenue
—
Stock compensation / revenue
0.5%

Ownership (13F)

3 metrics
13F filers
1,341
13F filer change QoQ
-91
Institutional ownership
60.1%

Short interest

3 metrics
Short interest
2.8%
Latest settlement · 5.6 days to cover
Days to cover
5.6d
Short-squeeze score
65 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 860730 CUSIP 40412C101 13F (30d) 815 filings 796 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)